Functional characterization of osteosarcoma cell lines provides representative models to study the human disease

Laboratory Investigation

Volumn 91, Issue 8, 2011, Pages 1195-1205

  Mohseny, Alexander B ^a   MacHado, Isidro ^b   Cai, Yongping ^a,c   Schaefer, Karl Ludwig ^d   Serra, Massimo ^e   Hogendoorn, Pancras C W ^a   Llombart Bosch, Antonio ^b   Cleton Jansen, Anne Marie ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF VALENCIA   (Spain)

^c SHANDONG UNIVERSITY   (China)

^d University Medical Center Duesseldorf   (Germany)

^e RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

contamination; HOS; misidentification; MNNG; origin; tumorigenesis; U2OS

Indexed keywords

ADIPOCYTE; ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER INVASION; CANCER RESEARCH; CARCINOGENESIS; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; FEMALE; GENETICS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; MOUSE; NEOPLASM; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BONE NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; SARCOMA, EXPERIMENTAL;

EID: 79960909993     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.72     Document Type: Article

References (42)

1. Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2002;24:315-319. (Pubitemid 37336517)
2. Chu D, Zheng J, Wang W, et al. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status. Ann Surg Oncol 2009.
3. Zhong Y, Onuki J, Yamasaki T, et al. Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. Carcinogenesis 2009;301:158-164.
4. Xu L, Ding Y, Catalona WJ, et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 2009.
5. Xu Z, Chen ZP, Malapetsa A, et al. DNA repair protein levels vis-a-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program. Anticancer Drugs 2002;135:511-519. (Pubitemid 34621055)
6. Scheper MA, Shirtliff ME, Meiller TF, et al. Farnesol, a fungal quorumsensing molecule triggers apoptosis in human oral squamous carcinoma cells. Neoplasia 2008;109:954-963.
7. Vescio RA, Connors KM, Kubota T, et al. Correlation of histology and drug response of human tumors grown in native-state threedimensional histoculture and in nude mice. Proc Natl Acad Sci USA 1991;8812:5163-5166. (Pubitemid 21914704)
8. Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 2010;104:241-253.
9. Arlett CF. The use of dubious cell lines in research: is trust enough? Lancet Oncol 2001;28:467.
10. Drexler HG, Dirks WG, Matsuo Y, et al. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 2003;172:416-426. (Pubitemid 36266920)
11. Masters JR. Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 2000;13:233-236.
12. Drexler HG, Uphoff CC, Dirks WG, et al. Mix-ups and mycoplasma: the enemies within. Leuk Res 2002;264:329-333. (Pubitemid 34143045)
13. Webster JA, Beck AH, Sharma M, et al. Variations in stromal signatures in breast and colorectal cancer metastases. J Pathol 2010;222:158-165.
14. Greshock J, Nathanson K, Martin AM, et al. Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Res 2007;678:3594-3600. (Pubitemid 46762143)
15. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;243:227-235. (Pubitemid 30132189)
16. Tinker AV, Boussioutas A, Bowtell DD. The challenges of gene expression microarrays for the study of human cancer. Cancer Cell 2006;95:333-339. (Pubitemid 43668729)
17. Douglas EJ, Fiegler H, Rowan A, et al. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 2004;6414:4817-4825. (Pubitemid 38924525)
18. Ottaviano L, Schaefer KL, Gajewski M, et al. Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosomes Cancer 2010;491:40-51.
19. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009;4587239:719-724.
20. Sandberg R, Ernberg I. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA 2005;1026:2052-2057. (Pubitemid 40262010)
21. Benini S, Baldini N, Manara MC, et al. Redundancy of autocrine loops in human osteosarcoma cells. Int J Cancer 1999;804:581-588. (Pubitemid 29047524)
22. Bruland OS, Fodstad O, Stenwig AE, et al. Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen. Cancer Res 1988;4818:5302-5309.
23. Fodstad O, Brogger A, Bruland O, et al. Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer 1986;381:33-40. (Pubitemid 16056255)
24. Schulz A, Battmann A, Heinrichs CM, et al. Properties and reactivity of a new human osteosarcoma cell line (HOS 58). Calcif Tissue Int 1993;52:30.
25. Kjonniksen I, Winderen M, Bruland O, et al. Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats. Cancer Res 1994;547:1715-1719. (Pubitemid 24116175)
26. Lombaerts M, van WT, Philippo K, et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 2006;945:661-671. (Pubitemid 43361897)
27. Mohseny AB, Szuhai K, Romeo S, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009;2193:294-305.
28. Van der Horst G, van Bezooijen RL, Deckers MM, et al. Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation. Bone 2002;316:661-669. (Pubitemid 36092088)
29. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;47:844-847. (Pubitemid 28331029)
30. Goethals L, Perneel C, Debucquoy A, et al. A new approach to the validation of tissue microarrays. J Pathol 2006;2085:607-614.
31. Bovee JVMG, Van den Broek LJCM, Cleton-Jansen AM, et al. Upregulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest 2000;80:1925-1933. (Pubitemid 32012760)
32. Romeo S, Bovée JVMG, Jadnanansing NAA, et al. Expression of cartilage growth plate signalling molecules in chondroblastoma. J Pathol 2004;2021:113-120. (Pubitemid 38072852)
33. Detre S, Saccani Jotti G, Dowsett M. A 'quickscore' method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995;489:876-878.
34. Da Costa CE, Szuhai K, van Eijk R, et al. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes Cancer 2009;483:239-249.
35. Van Eijk R, van Puijenbroek M, Chhatta AR, et al. Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues. J Mol Diagn 2010;12:27-34.
36. Ek ET, Dass CR, Choong PF. Commonly used mouse models of osteosarcoma. Crit Rev Oncol Hematol 2006;601:1-8. (Pubitemid 44349069)
37. Luu HH, Kang Q, Park JK, et al. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metast 2005;224:319-329. (Pubitemid 41374288)
38. Dass CR, Ek ET, Choong PF. Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing. J Cancer Res Clin Oncol 2007;1333:193-198. (Pubitemid 46144095)
39. Wunder JS, Gokgoz N, Parkes R, et al. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 2005;237: 1483-1490.
40. Gokgoz N, Wunder JS, Mousses S, et al. Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer 2001;928:2181-2189. (Pubitemid 32973330)
41. Torsvik A, Rosland GV, Svendsen A, et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects crosscontamination: putting the research field on track-letter. Cancer Res 2010;7015:6393-6396.
42. American Type Culture Collection Standards Development Organization Workgroup ASN-0002Alston-Roberts C Barallon R, Bauer SR, et al. Cell line misidentification: the beginning of the end. Nat Rev Cancer 2010;106:441-448.